Morningstar, Inc.
http://www.morningstar.com/Morningstar, Inc. (MORN) is an independent investment research company that provides data on more than 125,000 investment offerings, including stocks, mutual funds, and ETFs. The company offers its products and services through the Internet, software, and print for individuals, financial advisors, and institutions. The firm was founded in 1984 and is headquartered in Chicago, IL.
View Older Stories View More Recent Stories
-
Aristotle Funds Reduces Fees of Four Funds
-
BMO Launches New Structured Outcome ETF, Now Trading on Cboe Canada
-
Lawsuit demands menthol cigarette ban following White House delays
-
Teton Advisors, Inc. Reports Full Year and Fourth Quarter Results
-
GE completes three-way split, breaking off from its storied past
-
Biden administration US ban on menthol cigarettes delayed
-
Business Park Sofia Celebrates Wave of New and Renewed Leases
-
Kellanova Sets Date for 2024 First Quarter Results Webcast
-
Sprott Announces Expense Ratio Reduction for Sprott Uranium Miners ETF (NYSE Arca: URNM)
-
BMO Introduces New Structured Outcome ETF
-
CI Global Asset Management Announces Estimated Reinvested Distributions in Connection with Fund Mergers
-
Form ARS Morningstar, Inc. For: Mar 28
-
Nutrien (NTR) considering LatAm divestments after losses, management changes
-
Form DEFA14A Morningstar, Inc.
-
Form DEF 14A Morningstar, Inc. For: May 10
-
Royce Global Value Trust (NYSE: RGT) as of Feb 29, 2024
-
Exclusive-Nutrien mulls Latam divestments after losses, management exodus
-
Morningstar Publishes Fourth Annual Corporate Sustainability Report
-
VanEck Launches Value- and Growth-Oriented Versions of Their Popular Wide Moat Equity Strategy
-
RioCan Real Estate Investment Trust Completes Issuance of an Additional $150 Million of Series AJ Senior Unsecured Debentures
-
Baltimore bridge collapse likely to result in multibillion-dollar insurance claims -Lloyd's of London
-
Insurers could face losses of up to $4 billion after Baltimore bridge tragedy-analyst
-
Kimball Electronics Publishes Annual Sustainability Disclosures with its 2023 Guiding Principles Report
-
Wellspring Announces Closing of $975 Million Continuation Fund Partnering with Lexington Partners, Neuberger Berman, Hamilton Lane and AltamarCAM
-
Form 40-17G Morningstar Funds Trust
-
Ad hoc announcement: GAM announces 2023 full year results, proposal to strengthen the balance sheet and strategic progress
-
Factbox-Companies react to Baltimore bridge collapse
-
Ventas Earns ENERGY STAR® Partner of the Year Sustained Excellence in Energy Management Award
-
Morningstar Report Reveals Collective-Investment Trusts Poised to Overtake Mutual Funds in Target-Date Strategies in 2024
-
Recursion Publishes Annual Environmental, Social and Governance Report
-
UPS forecasts 2026 revenue above estimates on cost cuts, margin growth
-
Wealth Solutions Report Announces Pathfinder Awards Winners For Women's History Month
-
EIB's ESG score to be re-evaluated if new weapons policy agreed, Morningstar Sustainalytics says
-
RioCan Real Estate Investment Trust Announces Offering of an Additional $150 million of Series AJ Senior Unsecured Debentures
-
Ellington Financial Inc. Completes Proprietary Reverse Mortgage Loan Securitization
-
Morningstar, Inc. to Announce First-Quarter 2024 Financial Results on April 24
-
Outflows from Grayscale bitcoin ETF hit $1.9 billion in single week
-
Form NPORT-P Morningstar Funds Trust For: Jan 31
-
Form NPORT-P Morningstar Funds Trust For: Jan 31
-
Form NPORT-P Morningstar Funds Trust For: Jan 31
-
Form NPORT-P Morningstar Funds Trust For: Jan 31
-
Form NPORT-P Morningstar Funds Trust For: Jan 31
-
Form 8-K Morningstar, Inc. For: Mar 22
-
Bluerock Total Income+ Real Estate Fund Makes 45th Consecutive Quarterly Distribution at a 5.25% Annualized Rate
-
Nike warns of revenue dip as it cuts back on key products
-
FT Portfolios Canada Co. Announces Cash Distributions for Its Exchange Traded Funds
-
Impact Shares YWCA Women’s Empowerment ETF (WOMN) Reaches $50M in Assets Under Management
-
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
-
Phanes Therapeutics' PT886 granted Fast Track designation for the treatment of patients with metastatic claudin 18.2-positive pancreatic adenocarcinoma by the FDA
-
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

